Age and leukocyte count as prognostic factors on acute lymphoblastic leukemia: hgmlal07 cohort
Washington Ladines-Castro,
Adrián Santoyo-Sánchez,
Etta Rozen-Fuller,
Irma Olarte-Carrillo,
Adolfo Martínez-Tovar,
Humberto Castellanos-Sinco,
Juan Collazo-Jaloma,
Christian Omar Ramos-Peñafiel
Affiliations
Washington Ladines-Castro
Servicio de Hematología, Hospital General de México “Dr. Eduardo Liceaga”. Ciudad de México
Adrián Santoyo-Sánchez
Unidad de Medicina Experimental, Universidad Nacional Autónoma de México. Ciudad de México
Etta Rozen-Fuller
Servicio de Hematología, Hospital General de México “Dr. Eduardo Liceaga”. Ciudad de México
Irma Olarte-Carrillo
Laboratorio de Hematología, Hospital General de México “Dr. Eduardo Liceaga”. Ciudad de México
Adolfo Martínez-Tovar
Laboratorio de Hematología, Hospital General de México “Dr. Eduardo Liceaga”. Ciudad de México
Humberto Castellanos-Sinco
Servicio de Hematología, Hospital General de México “Dr. Eduardo Liceaga”. Ciudad de México
Juan Collazo-Jaloma
Servicio de Hematología, Hospital General de México “Dr. Eduardo Liceaga”. Ciudad de México
Christian Omar Ramos-Peñafiel
Servicio de Hematología, Hospital General de México “Dr. Eduardo Liceaga”. Ciudad de México – México / Departamento de Hematología, Hospital de Alta Especialidad Bicentenario del Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado.
In order to establish the cutoff with prognostic implications for white blood cell count and age at diagnosis in adults with acute lymphoblastic leukemia (ALL), we conducted an observational, descriptive and analytical study nested in a retrospective cohort of patients with ALL treated by institutional protocol HGMLAL07 during 2007-2014. We study 255 patients, the 52.9% (n=135) were female and 47.1% (n=120) were male. The mean age was 31 (16-80) years-old. The disease-free survival (DFS) decreases in both genders after 20 years-old (p = 0.001). Leukocyte count average was 56.1 x 109/L (0.1-850 x 109/L). DFS decreases significantly from an equal or greater leukocyte count of 20 x 109/L (p<0.05). With this results, we can conclude that use foreign cutoff for age and leukocyte count could determine a bad prognosis stratification and a consequent suboptimal treatment.